C12N 2770/24071
Demonstrated in vivo effect
C12N2770/24071 (Demonstrated in vivo effect) appears on 5 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 7
- Assignees
- 3
- Inventors
- 19
- Latest grant
- 8 Oct 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 0 | 2 |
| 2022 | 1 | 0 |
| 2023 | 2 | 2 |
| 2024 | 2 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Zika vaccines and immunogenic compositions, and methods of using the same8 Oct 2024US 12,109,260 B2Takeda Vaccines, Inc.
- Method for inactivating zika virus and for determining the completeness of inactivation23 Apr 2024US 11,964,008 B2Takeda Vaccines, Inc.
- Zika vaccines and immunogenic compositions, and methods of using the same22 Aug 2023US 11,730,802 B2Takeda Vaccines, Inc.
- Zika vaccines and immunogenic compositions, and methods of using the same16 May 2023US 11,648,304 B2Takeda Vaccines, Inc.
- Method for inactivating Zika virus and for determining the completeness of inactivation25 Oct 2022US 11,478,541 B2Takeda Vaccines, Inc.
- Nucleic acid compositions for delivering exogenous polynucleotides and methods of use29 May 2025US 2025/0171802 A1Vyro Bio Inc.
- Method for inactivating zika virus and for determining the completeness of inactivation3 Oct 2024US 2024/0325518 A1Takeda Vaccines, Inc.
- Zika vaccines and immunogenic compositions, and methods of using the same28 Dec 2023US 2023/0414743 A1Takeda Vaccines, Inc.
- Method for inactivating zika virus and for determining the completeness of inactivation11 May 2023US 2023/0145065 A1Takeda Vaccines, Inc.
- Zika vaccines and immunogenic compositions, and methods of using the same17 Jun 2021US 2021/0177958 A1Takeda Vaccines, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.